Bank Of New York Mellon Corp Glaukos Corp Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$43.88 - $52.48 $19.3 Million - $23.1 Million	440,509 New	440,509 $22.1 Billion
Q4 2022 Feb 14, 2023	BUY	$40.82 - $57.75 $18.4 Million - $26 Million	450,009 New	450,009 $19.7 Million
Q3 2022 Nov 14, 2022	BUY	$46.84 - $58.49 $590,371 - $737,207	12,604 Added 2.75%	470,804 $25.1 Million
Q2 2022 Aug 15, 2022	SELL	$34.86 - $63.77 $802,756 - $1.47 Million	-23,028 Reduced 4.79%	458,200 $20.8 Million
Q1 2022 May 11, 2022	BUY	$44.33 - $57.82 $126,030 - $164,382	2,843 Added 0.59%	481,228 $27.8 Million
Q4 2021 Feb 11, 2022	BUY	$40.27 - $56.99 $515,174 - $729,073	12,793 Added 2.75%	478,385 $21.3 Million
Q3 2021 Nov 12, 2021	BUY	$47.43 - $84.23 $289,512 - $514,139	6,104 Added 1.33%	465,592 $22.4 Million
Q2 2021 Aug 11, 2021	SELL	$73.06 - $97.7 $565,338 - $756,002	-7,738 Reduced 1.66%	459,488 $39 Million
Q1 2021 May 13, 2021	BUY	$70.43 - $97.42 $836,285 - $1.16 Million	11,874 Added 2.61%	467,226 $39.2 Million
Q4 2020 Feb 09, 2021	SELL	$48.9 - $75.26 $365,234 - $562,116	-7,469 Reduced 1.61%	455,352 $34.3 Million
Q3 2020 Nov 12, 2020	BUY	$37.23 - $50.97 $824,942 - $1.13 Million	22,158 Added 5.03%	462,821 $22.9 Million
Q2 2020 Aug 12, 2020	BUY	$28.78 - $46.83 $636,671 - $1.04 Million	22,122 Added 5.29%	440,663 $16.9 Million
Q1 2020 May 06, 2020	BUY	$25.53 - $70.14 $6.06 Million - $16.6 Million	237,199 Added 130.8%	418,541 $12.9 Million
Q4 2019 Feb 14, 2020	BUY	$54.18 - $65.64 $1.03 Million - $1.24 Million	18,929 Added 11.65%	181,342 $9.88 Million
Q3 2019 Nov 07, 2019	SELL	$58.58 - $83.91 $532,726 - $763,077	-9,094 Reduced 5.3%	162,413 $10.2 Million
Q2 2019 Aug 12, 2019	SELL	$63.59 - $78.71 $581,466 - $719,724	-9,144 Reduced 5.06%	171,507 $12.9 Million
Q1 2019 May 14, 2019	BUY	$50.75 - $80.54 $642,545 - $1.02 Million	12,661 Added 7.54%	180,651 $14.2 Million
Q4 2018 Feb 11, 2019	SELL	$52.18 - $67.93 $1.04 Million - $1.36 Million	-19,991 Reduced 10.63%	167,990 $9.44 Million
Q3 2018 Nov 09, 2018	BUY	$38.13 - $68.37 $644,816 - $1.16 Million	16,911 Added 9.89%	187,981 $0
Q2 2018 Aug 06, 2018	BUY	$27.62 - $44.51 $591,620 - $953,404	21,420 Added 14.31%	171,070 $6.95 Million
Q1 2018 May 15, 2018	BUY	$26.05 - $34.5 $818,881 - $1.08 Million	31,435 Added 26.59%	149,650 $4.61 Million
Q4 2017 Feb 09, 2018	BUY	$24.5 - $36.01 $2.9 Million - $4.26 Million	118,215	118,215 $3.03 Million

Others Institutions Holding GKOS

# of Institutions

342

Shares Held

47.1M

Call Options Held

132K

Put Options Held

188K

Black Rock Inc. New York, NY

8.04M
Shares

$1.15 Billion
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

5.87M
Shares

$838 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

2.18M
Shares

$312 Million
0.05% of portfolio
State Street Corp Boston, MA

1.95M
Shares

$279 Million
0.01% of portfolio
Ameriprise Financial Inc Minneapolis, MN

1.64M
Shares

$234 Million
0.06% of portfolio

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.79B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account